Sophia Gaulkin assists clients across a range of pre- and post-market regulatory matters relating to dietary supplements, food products, drugs, medical devices, pet products, cosmetics, and consumer products. Ms. Gaulkin specializes in state and federal transparency reporting, with particular attention to state drug pricing reporting and enforcement. In addition, Ms. Gaulkin advises clients on health care fraud and abuse laws, FDA restrictions on promotion, and state drug and device marketing laws.